FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090022 [Registered on: 02/07/2025] Trial Registered Prospectively
Last Modified On: 02/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Yoga and pranayam]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of garbhasanskara in second trimester of pregnancy.  
Scientific Title of Study   Randomized Controlled Trial to Evaluate the Efficacy of Kashmarya-Madhuka Granules Along with Yoga & Pranayama as an Aspect of Garbhasanskara in Second Trimester of Pregnancy. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yogita Kumari 
Designation  M. S. Scholar 
Affiliation  Madan Mohan Malviya Government Ayurveda College, Udaipur 
Address  PG Dept. of Prasuti Tantra Evam Striroga, Madan Mohan Malviya Government Ayurved College, Radaji Circle, Ambamata, Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  6375776201  
Fax    
Email  dryogita.ptsr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anu M S 
Designation  Lecturer / Assistant Professor 
Affiliation  Madan Mohan Malviya Government Ayurved College, Udaipur 
Address  PG Dept. of Prasuti Tantra Evam Striroga, Madan Mohan Malviya Government Ayurved College, Radaji Circle, Ambamata, Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  8780511929  
Fax    
Email  dranuvaidhya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anu M S 
Designation  Lecturer / Assistant Professor 
Affiliation  Madan Mohan Malviya Government Ayurved College, Udaipur 
Address  PG Dept. of Prasuti Tantra Evam Striroga, Madan Mohan Malviya Government Ayurved College, Radaji Circle, Ambamata, Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  8780511929  
Fax    
Email  dranuvaidhya@gmail.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Govt. Ayurved College, Radaji Circle, Ambamata, Udaipur, Rajasthan 
 
Primary Sponsor  
Name  Madan Mohan Malviya Govt. Ayurved College 
Address  Madan Mohan Malviya Govt. Ayurved College, Radaji Circle, Ambamata, Udaipur, Rajasthan 313001  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yogita Kumari  Madan Mohan Malviya Government Ayurveda College And Hospitals, Udaipur  OPD no. 06, Government Ayurveda Hospital, Motichohattah, Udaipur (Affiliated hospital of Madan Mohan Malviya Government Ayurved College)
Udaipur
RAJASTHAN 
6375776201

dryogita.ptsr@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, M. M. M. Govt. Ayurved College, Udaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:Z349||Encounter for supervision of normal pregnancy, unspecified. Ayurveda Condition: GARBAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-IFA tab (60 mg of elemental iron and 0.5 mg of folic acid) Calcium tab (500 mg of Calcium with 250 I.U. Vitamin D3)
2Intervention ArmDrugClassical(1) Medicine Name: Kashmarya Madhuka Granules, Reference: Charak Samhita, Chikitsa sthan, Chapter-28/15-16, Route: Oral, Dosage Form: Khanda /Granules, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 12 Weeks, anupAna/sahapAna: Yes(details: Cow milk (Godugdha)), Additional Information: Intervention also includes Yoga & Pranayama as per SOP in Preconceptional and Prenatal Care Through Ayurveda Published by AIIA, New Delhi and routine ANC Supplementation - IFA tab (60 mg of elemental iron and 0.5 mg of folic acid) Calcium tab (500 mg of Calcium with 250 I.U. Vitamin D3)
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.All pregnant women with known LMP between 13th -20th weeks of pregnancy.
 
 
ExclusionCriteria 
Details  1.Patients with hemoglobin less than 7gm%.
2.Pregnancy with uterine malformations and congenital defect of uterus.
3.Multiple pregnancy.
4.Pregnancy with uterine fibroid and carcinoma.
5.Pregnancy with cardiovascular diseases.
6.Pregnancy with known case of epilepsy.
7.Pregnant women who is under antipsychotics.
8.Pregnancy with any severe systemic illness.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Fetal wellbeing – assessed through fetal biometry with USG
2.Maternal wellbeing – assessed with Mid Upper Arm Circumference, Pregnancy Weight Gain etc. 
12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.Changes in maternal minor ailments.
2.Changes in the rate of complications in the second trimester of pregnancy.
3.Changes in maternal stress.
 
12 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is about a clinical evaluation of Kashmarya Madhuka granules along with Yoga and Pranayama as an aspect of Garbhasanskara in the second trimester of pregnancy with routine antenatal care (ANC), in comparison to routine antenatal care (ANC) alone. There will be 2 groups in the study-

Group A (Trial group): Will receive Kashmarya-Madhuka granules (5g twice daily after meals with Godugdha) for 12 weeks along with Yoga and Pranayama as per national prenatal protocols with IFA tab (60 mg of elemental iron and 0.5 mg of folic acid) and Calcium tab (500 mg of Calcium with 250 I.U. Vitamin D3).

Group B (Control group): IFA tab (60 mg of elemental iron and 0.5 mg of folic acid) and Calcium tab (500 mg of Calcium with 250 I.U. Vitamin D3).

Trial will be conducted for a period of 12 weeks (3 months). Follow-up will be done every 15 days with final assessment after 12 weeks based on subjective symptoms, objective parameters and lab investigations.

Outcome assessment will include

Primary outcomes: Fetal growth parameters (BPD, HC, AC, FL, AFI) and maternal nutritional status (weight gain and MUAC).

Secondary outcomes: Changes in common pregnancy complaints, maternal stress levels (PSS scale), and incidence of complications such as IUGR and pre-eclampsia.

The data will be analysed scientifically and statistically.

 
Close